Načítá se...

Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.

OBJECTIVE: To estimate the impact of cotrimoxazole prophylaxis on the survival of human immunodeficiency virus (HIV)-positive tuberculosis (TB) patients. METHODS: A cohort study with a historical comparison group was conducted. End-of-treatment outcomes and 18-month survival were compared between TB...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mwaungulu, Frank B. D., Floyd, Sian, Crampin, Amelia C., Kasimba, Simplex, Malema, Simon, Kanyongoloka, Huxley, Harries, Anthony D., Glynn, Judith R., Fine, Paul E. M.
Médium: Artigo
Jazyk:Inglês
Vydáno: World Health Organization 2004
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2622842/
https://ncbi.nlm.nih.gov/pubmed/15298226
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!